Reff kaplan

REFERENCES
Bayer JK, Rapee RM, Hiscock H, Ukoumunne OC, Mihaiopoulos C, Wake M.
Translational research to prevent internalizing problems in early childhood. Depress
Anxiety. 2011;28:50-57. Brent D, Emslie E, Clarke G, Wagner KD, Asarnow JR, Keller
M, Ritz, L, lyengar S, Abebe K, Birmaher B, Ryan N, Kennard B, Hughers C, DeBar L,
McCracken J, Strober M, Suddath R, Spirito A, Leonard H, Meham N, Fora G, Onorato
M, Zelazny J. Switching to another SSRI or to venlafaxine with or without cog-nitive
behavioral therapy for adolescents with SSRI-resistant depression: The TORIDA
Randomized Controlled Trial. JAMA. 2008:299:901-913. Correll CU, Kratocvil Cl,
March J. Developments in pediatric psychopharmacol-ogy: Focus on stimulants,
antidepressants and antipsychotics. J Clin Psychiatry. 2011;72:655-670. Christiansen E,
Larsen KJ. Young people's risk of suicide attempts after contact with a psychiatric
departmentA nested case-control design using Danish reg-ister data. J Child Psycho!
Psychiatry. 2011;52:102. Field T. Prenatal depression effects on early development: A
review. Infant Behav Dev. 201104:1-14. Frodl T, Reinhold E, Koutsoulieris N, Donohoe
G, Bondy B, Reiser M, Moller Hi, Meisenzahl EM. Childhood stress, serotonin
transporter gene and brain struc-tures in major depression. Neuropsychopharmacology.
2010;35:1383-1390. Gould MS, Greenberg T, Velting DM, Shaffer D. Youth suicide risk
and preven-tive interventions: A review of the past ten years. I Am Acad Child Adolesc
Psychiatry. 2003;42:386. Hall WD. How have the SSRI antidepressants affected suicide
risk? Lancet. 2006; 367(9527):1959. Harm J, Kiive E. Droplets of black bile?
Development of vulnerability and resil-ience to depression in young age.
Psychoneuroendocrinology. 2011;36:380-392. Heiligenstein JH, Hoog SL, Wagner KD,
Findling RL, Galli N, Kaplan S, Busner J, Nilsson ME, Brown EB, Jacobson JG.
Fluoxetine 40-60 mg versus fluoxetine 20 mg in the treatment of children and adolescents
with a less-than-complete response to nine-week treatment with fluoxetine 10-20 mg: A
pilot study. J Child Adolesc Psychopharmacol. 2006;1/2:207. Hughes CW, Emslie GJ,
Crimson ML, Posner K, Birmaher B, Ryan N, Jensen P, Curry J, Vitiello B, Lopez M,
Shon SP, Piszka SR, Trivedi MH, and The Texas Consensus Conference Panel on
Medication Treatment of Childhood Major Depressive Disorder. Texas Children's
Medication Algorithm Project: Update from Texas Consensus Conference Panel on
medication treatment of childhood major depressive disorder. J Am Acad Child Adolesc
Psychiatry. 2007;46:667-686. Kaess M, Parzer P, Haffner J, Steen Rm, Roos J, Klett M,
Brunner R, Resch F. Explaining gender differences in non-fatal suicidal behavior among
adolescents: A population-based study. BMC Pub Health. 2011: 597-603. Luby J, Lenze
5, Tillman R. A novel early intervention for preschool depression: Findings from a pilot
randomized controlled trial. J Child Psycho! and Psychia-try 2011:1-10. March J, Silva S,
Petrycki S. The TADS Team. The Treatment for Adolescents with Depression Study
(TADS): Long-term effectiveness and safety outcomes. Arch Gen Psychiatry
2007;64:1132-1143. Newton AS, Hamm MP, Bethel! J, Rhodes AE, Bryan CJ, Tjosvold
L, Ali S, Logue E, Manion ID. Pediatric suicide-related presentations: A systematic
review of mental health care in the emergency room department. Ann Emerg Med.
2010;56:649-659. Nock MK, Hwang I, Sampson N, Kessler RC, Angermeyer M,
Beautrais A, Borges G, Bromet E, Bruffaerts R, de Girolamo G, de Graaf R, Florescu 5,
Gureje 0, Haro JM, Hu C, Huang Y, Karam EG, Kawakami N, Kovess V, Levinson D,

Postada-Villa _I, Sagar R, Tomov T, Viana MC, Williams DR. Cross-national analysis of
the associations among mental disorders and sui-cidal behavior: Findings from the WHO
World Mental Health Surveys. PLoS Med. 2009;6:1-13. Olfson M, Shaffer D, Marcus
SC, Greenberg T. Relationship between antidepres-sant medication treatment and suicide
in adolescents. Arch Gen Psychiatry. 2003;60:978. Rosso IM, Cintron CM, Steingard RJ,
Renshaw PF, Young AD, Yurgelun-Todd DA. Amygdala and hippocampus volumes in
pediatric major depression. Biol Psychiatry 2005;57(1):21. Von Knorring AL, Olsson GI,
Thomson PH, Lemming OM, Hulten A. A random-ized, double-blind, placebo-controlled
study of citalopram in adolescents with major depressive disorder. J Clin
Psychopharmacol. 2006;26:3 11. Wagner KD. Pharmacotherapy for major depression in
children and adolescents. Prog Neuropsychopharrnacol Biol Psychiatry 2005;29:819.
Wagner KD, Brent DA. Depressive disorders and suicide in children and ado-lescents. In:
Sadock BJ, Sadock VA, Ruiz P, eds. Kaplan & Sadock's Compre-hensive Textbook of.
Psychiatry 9th ed. Vol. 2. Lippincott Williams & Wilkins; 2009:3652. Whittington CJ,
Kendall T, Fonagy P, Cotrell D, Cotgrove A, Boddington E. Selec-tive serotonin reuptake
inhibitors in childhood depression: Systematic review of published versus unpublished
data. Lancet. 2004;363:1341_ Zalsman G. Timing is critical: gene, environment and
timing interactions in genet-ics of suicide in children and adolescents_ Eur Psychiatry.
2010:25:284-286.